Related Experiment Videos
Toxicology studies of fenbufen
Arzneimittel-Forschung
|January 1, 1980
Summary
Fenbufen, a non-steroidal anti-inflammatory drug, showed gastrointestinal and renal toxicity in animal studies. Coadministration with acetylsalicylic acid reduced fenbufen levels and may increase gastrointestinal bleeding risks.
Area of Science:
- Pharmacology and Toxicology
- Drug Safety Evaluation
Background:
- Fenbufen is a novel non-steroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic properties.
- Understanding the toxicity profile of fenbufen is crucial for its clinical application.
Purpose of the Study:
- To investigate the acute, subacute, and chronic toxicity of fenbufen in preclinical animal models.
- To assess potential adverse interactions of fenbufen when coadministered with other common medications.
Main Methods:
- Toxicity studies were conducted in mice, rats, and dogs using oral and parenteral administration of fenbufen.
- Coadministration studies involved combining fenbufen with dicoumarol, triamcinolone, and acetylsalicylic acid (ASA).
Main Results:
- Toxic doses of fenbufen induced gastrointestinal and renal changes consistent with NSAID-class effects.
- No specific adverse interactions were observed between fenbufen and dicoumarol or triamcinolone.
- Coadministration with acetylsalicylic acid led to reduced fenbufen plasma concentrations and a potential increase in gastrointestinal hemorrhages or ulcers.
Conclusions:
- Fenbufen exhibits NSAID-like toxicity, primarily affecting the gastrointestinal and renal systems.
- Concurrent administration of fenbufen with acetylsalicylic acid warrants caution due to potential pharmacokinetic interactions and increased risk of gastrointestinal complications.